Borok, Raphael

Borok, Raphael was paid $2.30M by Medicaid between Jan 2018 and Dec 2024, across 126 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 9.8% of everything it billed.

Compared with peers

Next to other Anatomic Pathology & Clinical Pathology Physician providers in Illinois

Rank by total paid#31 of 398

Median peer was paid$66K

This provider vs. median35×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	43,451	$192K
2019	84,941	$417K
2020	50,772	$260K
2021	54,476	$439K
2022	60,306	$478K
2023	47,930	$281K
2024incomplete	43,593	$233K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	9.8%	3,850	2,611	$225K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	9.3%	2,812	2,709	$214K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	8.7%	8,866	7,401	$201K
80053	Comprehensive metabolic panel	8.2%	37,357	23,171	$190K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	6.8%	54,771	33,545	$157K
80048	Basic metabolic panel (calcium, ionized)	5.4%	29,943	17,190	$125K
83735		4.1%	26,233	13,011	$95K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	3.4%	454	411	$77K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	2.8%	2,903	2,805	$63K
87040		2.3%	6,461	3,739	$54K
84484		2.2%	12,456	9,014	$50K
84443	Thyroid stimulating hormone (TSH)	2.0%	5,654	5,041	$46K

114 more codes

85027		2.0%	16,002	$46K
83690		1.7%	11,225	$39K
83880		1.6%	3,300	$38K
87641		1.5%	1,489	$34K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	1.4%	1,479	$33K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	1.4%	1,465	$32K
88305	Level IV - Surgical pathology, gross and microscopic examination	1.3%	669	$30K
87086	Culture, bacterial; quantitative colony count, urine	1.2%	5,344	$28K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	1.0%	891	$24K
80076		<1%	5,962	$22K
82803		<1%	2,502	$21K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	606	$21K
84100		<1%	9,033	$20K
85730		<1%	6,337	$20K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	1,920	$19K
83605		<1%	4,215	$19K
86901		<1%	7,860	$17K
88377		<1%	382	$17K
85379		<1%	4,294	$17K
85610		<1%	8,026	$16K
81001		<1%	11,857	$15K
80061	Lipid panel	<1%	4,817	$14K
86850		<1%	4,674	$14K
84703		<1%	3,833	$13K
86900		<1%	7,855	$13K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	1,537	$12K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	491	$12K
83036	Hemoglobin; glycosylated (A1C)	<1%	3,935	$12K
85390		<1%	2,002	$12K
84132		<1%	4,002	$8K
85060		<1%	585	$8K
82550		<1%	2,459	$7K
86780		<1%	864	$7K
82248		<1%	3,410	$7K
82247		<1%	3,055	$7K
87186		<1%	931	$6K
86140		<1%	2,479	$6K
87070		<1%	1,706	$5K
82728		<1%	1,430	$5K
84702		<1%	1,127	$5K
84481		<1%	862	$4K
84439		<1%	881	$4K
81003		<1%	3,490	$4K
82565		<1%	1,610	$4K
82607		<1%	591	$4K
87075		<1%	503	$3K
87205		<1%	1,810	$3K
84165		<1%	863	$3K
87081		<1%	1,097	$3K
85018		<1%	2,877	$3K
86334		<1%	363	$3K
83550		<1%	651	$3K
82077		<1%	188	$3K
82805		<1%	464	$3K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	558	$2K
82746		<1%	425	$2K
86880		<1%	844	$2K
85014		<1%	2,080	$2K
81025		<1%	1,684	$2K
85652		<1%	1,765	$2K
88342		<1%	196	$2K
82570		<1%	927	$2K
80164		<1%	433	$2K
88363		<1%	225	$2K
82140		<1%	457	$2K
82150		<1%	522	$2K
83615		<1%	585	$2K
84480		<1%	397	$2K
87210		<1%	692	$2K
87807		<1%	263	$1K
84145		<1%	1,059	$1K
84436		<1%	379	$1K
87088		<1%	214	$1K
84153		<1%	179	$1K
87507		<1%	33	$1K
87077		<1%	396	$1K
82375		<1%	436	$969.84
87340		<1%	146	$957.87
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	27	$953.91
82378		<1%	135	$899.14
84550		<1%	506	$845.52
86038		<1%	106	$809.15
82962		<1%	711	$781.21
80202		<1%	102	$677.28
85651		<1%	282	$648.60
G0452	Molecular pathology procedure; physician interpretation and report	<1%	202	$646.28
86592		<1%	329	$642.00
83050		<1%	427	$611.44
85384		<1%	195	$592.84
87493		<1%	24	$526.93
84166		<1%	153	$521.25
88341		<1%	15	$518.99
87390		<1%	44	$506.00
86706		<1%	58	$389.70
86480		<1%	14	$363.58
88307		<1%	12	$305.20
86803		<1%	37	$293.62
86701		<1%	44	$278.64
84156		<1%	248	$273.70
82043		<1%	132	$258.07
84300		<1%	105	$220.48
86702		<1%	44	$219.30
88291		<1%	18	$198.50
86704		<1%	27	$193.75
86335		<1%	20	$110.70
82553		<1%	37	$100.17
80320		<1%	2,143	$88.25
83540		<1%	28	$69.85
80329		<1%	67	$64.00
82010		<1%	24	$48.40
85046		<1%	14	$35.62
83935		<1%	13	$30.29
84295		<1%	27	$21.83
85007		<1%	144	$19.25

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.